RIP2 polymorphisms in inflammatory bowel diseases^†

R. Thiébaut

UMR843, INSERM, Assistance Publique Hopitaux de Paris et Université, Paris Diderot, Paris, France

V. Douchin PhD

UMR843, INSERM, Assistance Publique Hopitaux de Paris et Université, Paris Diderot, Paris, France

C. Jung MD

UMR843, INSERM, Assistance Publique Hopitaux de Paris et Université, Paris Diderot, Paris, France

F. Merlin

UMR843, INSERM, Assistance Publique Hopitaux de Paris et Université, Paris Diderot, Paris, France

J.F. Colombel MD, PhD

Registre EPIMAD, Service d'Epidémiologie et de Santé Publique, Hôpital Calmette, Lille, France

M. Lemann MD, PhD

GETAID, Service de gastroentérologie, Hopital Saint Louis, Paris, France

S. Almer MD, PhD

Institutionen för Klinisk och Experimentell medicin/IKE, Linköpings universitet, EM-kliniken, Universitessjukhuset, Linköping, Sweden

C. Tysk MD, PhD

Örebro University Hospital and School of Health and Medical Sciences, Örebro, Sweden

C. O'Morain MD, PhD

Adelaide & Meath Hospital and Faculty of Health Sciences, Trinity College, Dublin, Ireland

M. Gassull MD, PhD

Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Y. Finkel MD, PhD

Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden

H. Zouali PhD

Fondation Jean Dausset, CEPH, Paris, France

L. Pascoe PhD

Fondation Jean Dausset, CEPH, Paris, France

J.P. Hugot MD, PhD

UMR843, INSERM, Assistance Publique Hopitaux de Paris et Université, Paris Diderot, Paris, France